Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

This is a summary of: Liu. H. et al. Viral RNA blocks circularization to evade host codon usage control. Nature https://doi.org/10.1038/s41586-025-09809-y (2025).

French newspaper La Lettre said the Paris-based biotech – which is listed on the Nasdaq – has been on Lilly's radar after ...

Cell division is an essential process for all life on Earth, yet the exact mechanisms by which cells divide during early ...

Scientists have uncovered a new explanation for how swimming bacteria change direction, providing fresh insight into one of ...

Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how ...